Ioannis Psallidas, MD, PhD, FCCP, Associate Professor - Global Clinical Head, Respiratory & Immunology - AstraZeneca | LinkedIn
CONGRESS GUIDE
PDF) Diagnostic Value and Prognostic Significance of Pleural C-Reactive Protein in Lung Cancer Patients with Malignant Pleural Effusions
PDF) The management of benign non-infective pleural effusions
70+ "Ioannis M.d" profiles | LinkedIn
Ioannis PSALLIDAS | Consultant | MD, PhD FCCP | University College London, London | UCL | UCL Respiratory
Dr. Jason A. Akulian, MD | Chapel Hill, NC | Pulmonologist | US News Doctors
Ioannis PSALLIDAS | Consultant | MD, PhD FCCP | University College London, London | UCL | UCL Respiratory
Table of Contents — August 01, 2019, 54 (2) | European Respiratory Society
Ioannis PSALLIDAS | Consultant | MD, PhD FCCP | University College London, London | UCL | UCL Respiratory
PDF) Osteopontin is not a specific marker in malignant pleural mesothelioma
Supplemental Materials for Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis - The Lancet Oncology
Malignant pleural effusion: from bench to bedside.” Ioannis Psallidas, Ioannis Kalomenidis, Jose M. Porcel, Bruce W. Robinson and Georgios T. Stathopoulos. Eur Respir Rev 2016; 25: 189–198. | European Respiratory Society
Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion. - Abstract - Europe PMC
Ioannis Psallidas, CISSP, CISA, CRISC, COBIT5F - Director-Assurance of Infrastructures and Privacy of Services and Internet Applications Division - Hellenic Authority for Communication Security and Privacy | LinkedIn
Ioannis Psallidas, MD, PhD, FCCP, Associate Professor - Global Clinical Head, Respiratory & Immunology - AstraZeneca | LinkedIn
Osteopontin is upregulated in malignant and inflammatory pleural effusions - MOSCHOS - 2009 - Respirology - Wiley Online Library
Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial.,The Lancet Respiratory Medicine - X-MOL
PDF) Navafenterol (AZD8871) in patients with mild asthma: a randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of this novel inhaled long-acting dual ...
Observation of a new excited beauty strange baryon decaying to $\Xi_{\mathrm{b}}^{-}\pi^{+}\pi^{-}$ - CERN Document Server
FinalProgram PDF | Pulmonology | Physical Therapy
PDF) The Effect of Silver Nitrate Pleurodesis after a Failed Thoracoscopic Talc Poudrage
Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial.,The Lancet Respiratory Medicine - X-MOL
Ioannis Psallidas | hosco.
